# Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

> **NCT01840007** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 20 (actual)

## Conditions studied

- Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)

## Interventions

- **DRUG:** Metformin Group

## Key facts

- **NCT ID:** NCT01840007
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-30
- **Primary completion:** 2015-05-28
- **Final completion:** 2015-11-18
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01840007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01840007, "Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01840007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*